Comparing the current results to its competitors, Icon Plc reported Revenue decrease in the 4 quarter 2025 year on year by -0.37 %, despite the revenue increase by the most of its competitors of 1.62 %, recorded in the same quarter.
Icon Plc, slower than the average decrease reported by the company's competitors of -95 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -95 %
Icon Plc's Comment on Competition and Industry Peers
The contract research organization (CRO) industry is fragmented, consisting of many small niche providers, fewer medium-sized firms, and a smaller number of large CROs distinguished by global scale, service breadth, and technology. ICON primarily competes with IQVIA, PAREXEL, the PPD clinical research services brand of Thermo Fisher Scientific Inc., Fortrea, and Syneos Health for large development programs. In markets such as biotechnology and mid-tier pharmaceutical companies, ICON also faces competition from mid-tier CROs. Competition involves acquisition targets and customers and is based on factors including operational experience, global patient recruitment capabilities, therapeutic and scientific expertise, project team strength, pricing, and innovation. A developing area of competition involves providing services that generate evidence of economic value for new treatments, which requires access to new data sources.
Medpace Holdings Inc is a contract research organization (CRO) that provides various services in the clinical research and development of drugs and medical devices.
Simulations Plus Inc operates in the pharmaceutical and biotechnology industries, providing simulation software and consulting services to assist in drug development processes.
Sources:
Icon Plc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Icon Plc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
